| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030051 |
| Receipt No. | R000034312 |
| Scientific Title | Effect of recumbent yoga on patients with CFS |
| Date of disclosure of the study information | 2017/11/20 |
| Last modified on | 2020/05/23 (Ver. 6) |
| Basic information | ||
| Public title | Effect of recumbent yoga on patients with CFS | |
| Acronym | Recumbent yoga for CFS | |
| Scientific Title | Effect of recumbent yoga on patients with CFS | |
| Scientific Title:Acronym | Recumbent yoga for CFS | |
| Region |
|
|
| Condition | ||
| Condition | chronic fatigue syndrome | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To elucidate the effect of recumbent isometric yoga on severe patients with chronic fatigue syndrome. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Before and after intervention period (12 weeks)
severity of fatigue 1) Chalder's fatigue scale score 2) POMS F score |
| Key secondary outcomes | Blood biomarkers such as DHEA-S, IFNg, IL-6 etc, autonomic nervous function, surface body temperature, fMRI. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | standard pharmacotherapy | |
| Interventions/Control_2 | pharmacotherapy + 20 min/day, daily recumbent isometric yoga | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects were outpatients with CFS who visited the Department of Psychosomatic Medicine, International University of Health and Welfare Hospital who didn't recover satisfactory in spite of the treatments for at least 6 months. | |||
| Key exclusion criteria | Patients were excluded if their fatigue was due to physical disease such as liver, kidney, heart, respiratory, endocrine, autoimmune, or malignant disease, severe anemia, electrolyte abnormalities, obesity, or pregnancy. | |||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | International University of Health and Welfare Hospital | ||||||
| Division name | Psychosomatic Medicine | ||||||
| Zip code | 329-2763 | ||||||
| Address | Iguchi 537-3, Basushiobara-shi, Tochi-gi | ||||||
| TEL | 0287-39-3060 | ||||||
| okatakakazu@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | International University of Health and Welfare Hospital | ||||||
| Division name | Psychosomatic Medicine | ||||||
| Zip code | 329-2763 | ||||||
| Address | Iguchi 537-3, Basushiobara-shi, Tochi-gi | ||||||
| TEL | 0287-39-3060 | ||||||
| Homepage URL | |||||||
| okatakakazu@gmail.com | |||||||
| Sponsor | |
| Institute | AMED |
| Institute | |
| Department | |
| Funding Source | |
| Organization | AMED |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | International University of Health and Welfare |
| Address | Nasushiobara, Tochigi |
| Tel | 0287-39-3060 |
| masa-takahashi@iuhw.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | n.a. |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | not published yet | ||||||
| Number of participants that the trial has enrolled | 48 | ||||||
| Results | Patients with CFS who were refractory to treatments as usual (TAU) were divided into recumbent isometric yoga group (TAU and recumbent isometric yoga, n=24) or control group (TAU only, n=24). The Chalder fatigue scale (FS) scores of the two groups were compared before and after the 3 - month intervention period. The FS score of the recumbent isometric yoga group decreased significantly compared with the control group. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | CFS patients (20-70 years old, regardless of gender) who visited our department |
||||||
| Participant flow | CFS patients who visit our outpatient department are randomly divided into two groups, one group that continues regular treatment (normal treatment group) and the other group that uses yoga for regular treatment (yoga combination group), and randomized comparison for 24 weeks Conduct the test. However, patients in the yoga group will learn yoga directly from the yoga teacher at outpatient visits every 2 to 4 weeks, and on other days, they will study yoga by watching You Tube at home. |
||||||
| Adverse events | None |
||||||
| Outcome measures | Chalder fatigue scale score. performance status, SF8, Hospital anxiety and depression scale (HADS), Profile of mood states (POMS) Autonomic nerve function test, body surface temperature, Blood biomarkers (DHEA-S, acylcarnitine, IFNg, IL6, TGFb1, BDNF, etc.) Brain image (fMRI), Dosage and adverse events, |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000034312 |